Fintel reports that on March 12, 2025, Evercore ISI Group initiated coverage of Summit Therapeutics (NasdaqGM:SMMT) with a ...

In a report released yesterday, David Motemaden from Evercore ISI maintained a Hold rating on Factset Research (FDS – Research Report), with a ...

Fintel reports that on March 11, 2025, Evercore ISI Group upgraded their outlook for CenterPoint Energy (NYSE:CNP) from ...

In a report released yesterday, David Motemaden from Evercore ISI maintained a Hold rating on Arch Capital Group (ACGL – Research Report), with ...

Capital One Financial (NYSE:COF) was upgraded by investment analysts at Evercore ISI from an “in-line” rating to an ...

NEW YORK, March 03, 2025--Evercore (NYSE: EVR) announced today that Joe Modisett has joined the firm as a senior managing director in the Healthcare Investment Banking group, based in New York.

Carvana (NYSE:CVNA – Free Report) had its price target lowered by Evercore ISI from $250.00 to $240.00 in a report issued on ...

Fintel reports that on February 14, 2025, Evercore ISI Group upgraded their outlook for CRISPR Therapeutics (BRSE:1CG) from In-Line to Outperform. There are 577 funds or institutions reporting ...

Evercore Group, or Lazard. Increasing Our Fair Value Estimate for Evercore to $166 From $158 Evercore’s revenue and earnings could experience a relatively tough year or two compared with the ...

Fintel reports that on February 6, 2025, Evercore ISI Group downgraded their outlook for Match Group (BRSE:4MGN) from Outperform to In-Line. There are 1,154 funds or institutions reporting ...

Evercore (NYSE: EVR) announced today that Joe Modisett has joined the firm as a senior managing director in the Healthcare Investment Banking group, based in New York. Naveen Nataraj, co-head of U ...

Montrose Environmental Group, Inc. (the "Company," "Montrose" or "MEG") (NYSE: MEG), a company on a mission to help protect the air we breathe, the water we drink, and the soil that feeds us, today ...